Summit Therapeutics PLC(SMMT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SMMT Summit Therapeutics PLC

Pre-Mkt 10-09 04:12:41 EDT

17.17

-0.78

-4.35%

盘前17.27

+0.10+0.58%

04:07 EDT

High17.64	Low16.80	Vol6.18M
Open17.61	D1 Closing17.95	Amplitude4.68%
Mkt Cap13.70B	Tradable Cap2.65B	Total Shares797.75M
T/O105.74M	T/O Rate4.00%	Tradable Shares154.32M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SMMT","market":"US","secType":"STK","nameCN":"Summit Therapeutics PLC","latestPrice":17.17,"timestamp":1791489600000,"preClose":17.95,"halted":0,"volume":6179332,"hourTrading":{"tag":"盘前","latestPrice":17.27,"preClose":17.17,"latestTime":"04:07 EDT","volume":1422,"amount":24558.002567999996,"timestamp":1791533253113,"change":0.1,"changeRate":0.005824,"amplitude":0.008084},"delay":0,"changeRate":-0.04345403899721435,"floatShares":154320004,"shares":797749602,"eps":-1.117703,"marketStatus":"Pre-Mkt","change":-0.78,"latestTime":"10-09 04:12:41 EDT","open":17.612,"high":17.6359,"low":16.795,"amount":105740500.548716,"amplitude":0.046847,"askPrice":17.47,"askSize":31,"bidPrice":17.21,"bidSize":31,"shortable":3,"etf":0,"ttmEps":-1.117703,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":1,"adrRate":5,"listingDate":1425531600000,"exchange":"NASDAQ","adjPreClose":17.17,"preHourTrading":{"tag":"盘前","latestPrice":17.27,"preClose":17.17,"latestTime":"04:07 EDT","volume":1422,"amount":24558.002567999996,"timestamp":1791533253113,"change":0.1,"changeRate":0.005824,"amplitude":0.008084},"postHourTrading":{"tag":"盘后","latestPrice":17.0547,"preClose":17.17,"latestTime":"19:49 EDT","volume":62459,"amount":1069821.0021,"timestamp":1791503397389,"change":-0.1153,"changeRate":-0.006715,"amplitude":0.013978},"volumeRatio":0.9528359663944513,"optionData":{"bulkOrders":[{"symbol":"SMMT","call":false,"expireDate":1799989200000,"strike":"9.0","timestamp":1791488212555,"price":0.5,"volume":1046,"amount":52300,"type":"-"}]},"impliedVol":1.1839,"impliedVolPercentile":0.844},"requestUrl":"/m/hq/s/SMMT/wiki","defaultTab":"wiki","newsList":[{"id":"1199774187","title":"Movement Alert｜Summit Therapeutics PLC Falls 5.13% in Regular Trading, Profit Taking After AstraZeneca Investment Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1199774187","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199774187?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:47","pubTimestamp":1791467258,"startTime":"0","endTime":"0","summary":"On October 8, Summit Therapeutics PLC fell 5.13% in regular trading, trading at $17.02/share, with Turnover of $10.31 million. The decline followed consecutive gains prompted by AstraZeneca's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Summit Therapeutics Falls on Profit Taking After AstraZeneca Investment","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101773808","title":"Movement Alert｜Summit Therapeutics PLC Intraday Rise 5.23%, AstraZeneca $2B Investment and Combination Therapy Collaboration Boost Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1101773808","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101773808?lang=en_us&edition=fundamental","pubTime":"2026-10-07 22:45","pubTimestamp":1791384300,"startTime":"0","endTime":"0","summary":"On October 7, Summit Therapeutics PLC rose 5.23% in regular trading, trading at $18.165/share, with Turnover of $45.85 million.The stock's strength was primarily driven by AstraZeneca's completion of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AstraZeneca $2B Investment Lifts Summit Therapeutics","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130109026","title":"Movement Alert｜Summit Therapeutics PLC Rises 5.1% in Regular Trading, AstraZeneca Closes $2 Billion Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1130109026","media":"Market Focus","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130109026?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:51","pubTimestamp":1791222682,"startTime":"0","endTime":"0","summary":"On October 6, Summit Therapeutics PLC rose 5.1% in Regular Trading, trading at $17.61 per share, with a turnover of $50.68 million. AstraZeneca finalized its $2 billion strategic equity investment in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Summit Surges on AstraZeneca $2 Billion Investment","news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044487","title":"AstraZeneca completes $2B equity investment in Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044487","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:12","pubTimestamp":1791198767,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced the successful closing of AstraZeneca’s (AZN) strategic equity investment in Summit. The equity investment wil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-completes-2b-equity-investment-in-summit-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443622.USD","LU0708994859.HKD","LU0128525929.USD","BK4539","LU0109394709.USD","IE00B3T34201.USD","LU2237443382.USD","LU2417539215.USD","LU1829250122.USD","LU2089984988.USD","AZNH","BK4588","LU2236285917.USD","LU0320765992.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2468319806.SGD","BK4007","LENZ","LU2237443549.SGD","LU0432979614.USD","LU0289739699.SGD","LU2488822045.USD","LU1267930573.SGD","BK4568","BK4585","LU2462157665.USD","LU0889565916.HKD","BK4139","LU2237443978.SGD","SMMT","LU0310800379.SGD","LU0029864427.USD","LU2456880835.USD","AZN","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673012701","title":"AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673012701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673012701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198009,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45Q01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK4139","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185122743","title":"Kia Ranks Second in UK Sales for First Eight Months of the Year, Trailing Only Volkswagen","url":"https://stock-news.laohu8.com/highlight/detail?id=1185122743","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185122743?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:40","pubTimestamp":1791168015,"startTime":"0","endTime":"0","summary":"Industry data released on Monday shows that Kia Motors ranked second in UK sales during the first eight months of this year, driven by strong demand for its Sportage sport utility vehicle...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SMMT","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672727362","title":"Summit Therapeutics (SMMT) Teams Up With AstraZeneca And Daiichi Sankyo, Is It 43% Undervalued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672727362","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672727362?lang=en_us&edition=fundamental","pubTime":"2026-10-04 14:15","pubTimestamp":1791094534,"startTime":"0","endTime":"0","summary":"AstraZeneca, Daiichi Sankyo and Summit Therapeutics (SMMT) have agreed to test Datroway with ivonescimab in multiple cancers, beginning with a Phase III trial in first line triple negative breast cancer.\nThe latest collaboration news lands after an active few weeks for Summit Therapeutics, including an equity investment from AstraZeneca at a conversion price of US$18.36 and additional clinical tie ups around ivonescimab across gastrointestinal and other tumor types. At a recent share price of...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-smmt/summit-therapeutics/news/summit-therapeutics-smmt-teams-up-with-astrazeneca-and-daiic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-smmt/summit-therapeutics/news/summit-therapeutics-smmt-teams-up-with-astrazeneca-and-daiic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2488822045.USD","BK4139","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672745865","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672745865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672745865?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:14","pubTimestamp":1790961293,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.3%.The iShares Biotechnology ETF  was shedding 0.7%.In corporate news, AstraZeneca  and Japan's Daiichi Sankyo have partnered with Summit Therapeutics  to test their drug Datroway plus ivonescimab to treat lung, breast, and other cancers, the companies said Friday. AstraZeneca shares were down 0.7%, and Summit rose 0.7%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800379.SGD","LU2468319806.SGD","LU2237443549.SGD","LU2488822045.USD","LU2089984988.USD","LU0029864427.USD","LU2417539215.USD","BK4007","LU0128526141.USD","LU2237443622.USD","BK4568","BK4585","LU0029874061.USD","LU2237443382.USD","HCSG","LU2462157665.USD","BK4139","XBI","SMMT","LU0128525929.USD","BK4137","LU0289739699.SGD","LU0889565916.HKD","LU1267930573.SGD","LU1829250122.USD","XLV","IE00B3T34201.USD","LU2456880835.USD","IBB","LU0058720904.USD","LU2236285917.USD","BK4588","LU0432979614.USD","LABU","LU2237443895.HKD","BK4581","LU0708994859.HKD","LU2237443465.HKD","AZNH","AZN","LU0320765992.SGD","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716909","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716909?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:39","pubTimestamp":1790937551,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsOct 2 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Friday:**  Europe's largest gas distributor Italgas said i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350502.SGD","LU2279689827.SGD","LU1015430645.USD","LU2114397693.USD","LU2293690249.USD","LU1301847155.USD","IE0034235188.USD","BAES.UK","LU0211327993.USD","LU0827474353.SGD","LU1267930813.SGD","LU2355687059.USD","LU0171276677.USD","AZN.UK","LU0171293334.USD","LU0029864427.USD","LU0496365809.HKD","LU1061106388.HKD","LU0266013472.USD","LU1814569148.SGD","LU2089284900.SGD","SG9999001176.SGD","LU0708994859.HKD","LU0997586515.USD","LU1019632923.USD","LU0784385170.HKD","LU1989771016.USD","LU2125909593.SGD","LU0011850046.USD","LU0957799991.USD","LU1064927863.SGD","LU1880407132.USD","LU1051770623.HKD","LU2324357040.USD","SMMT","LU1019634622.SGD","03165","LU0889565080.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU1267930573.SGD","LU2488822045.USD","LU0052756011.USD","LU1863844749.USD","LU2237443978.SGD","LU0557290698.USD","LU2293690082.USD","LU0882574055.USD","LU1153585028.USD","LU0976567544.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672107715","title":"Summit Therapeutics enters trial collaboration with AstraZeneca, Daiichi Sankyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672107715","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672107715?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:55","pubTimestamp":1790934913,"startTime":"0","endTime":"0","summary":"Summit Therapeutics (SMMT) announced a clinical trial collaboration agreement with Daiichi Sankyo (DSNKY) and AstraZeneca (AZN) to evaluate ivonesc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-enters-trial-collaboration-with-astrazeneca-daiichi-sankyo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU2456880835.USD","BK4585","LU2237443465.HKD","LU0058720904.USD","LU2468319806.SGD","LU0109394709.USD","MEDX","LU2237443549.SGD","LU2089984988.USD","LU0310800379.SGD","BK4139","HYLG","LU1829250122.USD","BK4588","LU0889565916.HKD","AZNH","GDOC","AZN","LU0708994859.HKD","SMMT","LU0289739699.SGD","DSNKY","LU2236285917.USD","BK4007","LU2462157665.USD","LU2237443978.SGD","IDNA","LENZ","LU0320765992.SGD","LU0432979614.USD","NVIB","LU1267930573.SGD","BK4568","IE00B3T34201.USD","BK4539","LU2237443622.USD","LU0128525929.USD","LU2237443895.HKD","LU2488822045.USD","LU2237443382.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00BFSS8Q28.SGD","LU0225283273.USD","IE00BKVL7J92.USD","LU0109391861.USD","SG9999014898.SGD","LU1481599808.USD","LU0499090636.EUR","LU1993786604.SGD","LU0607220059.USD","LU0122379950.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BQJZX424.USD","LU1496350502.SGD","IE0008369823.USD","LU2360032135.SGD","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","NVOC","LU1273509221.SGD","LU1244550494.USD","LU2580892862.HKD","LU1035775433.USD","AZN.UK","SG9999004220.SGD","IE00BJT1NW94.SGD","LU2596442595.SGD","LU0053666078.USD","LU0889565080.SGD","LU0109981661.USD","LU2552382132.HKD","LU1116320737.USD","WDNA","LU1019634622.SGD","BK1161","LU0203202063.USD","LU0289739343.SGD","LU0889566641.SGD","LU0540923850.HKD","LU1720051017.SGD","LU2125154935.USD","IE00BKDWB100.SGD","LU1066051811.HKD","LU1974910355.USD","LU2129689605.HKD","LU0266013472.USD","LU0795875086.SGD","LU0823416689.USD","IE00B4JS1V06.HKD","LU2362541513.USD","LLYZ","LU0997586515.USD","LU2097828474.EUR","LU2362541273.HKD","BK0183","HK0000165453.HKD","LU2491050154.USD","PFE","IE00B19Z3B42.SGD","LU1983299246.USD","THNR","09995","LU1496350171.SGD","LU1807302812.USD","LU0323591593.USD","BK0196","LU2039709279.SGD","LU0154236417.USD","BK0012","LU1400636657.SGD","IE00B42XCP33.USD","LU0417516738.SGD","IE00BK4W5L77.USD","LU1019632923.USD","LU2028103732.USD","LU1551013425.SGD","LU2646069778.SGD","IE00BK4W5M84.HKD","LU0997586432.USD","LU0072913022.USD","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0965509283.SGD","LU1226288170.HKD","LU0096364046.USD","LU0345777147.USD","LU0472753341.HKD","LU0385154629.USD","LU1934455277.USD","BK1593","LU2091194634.USD","LU1989772840.SGD","LU0244354667.USD","LU1670756490.USD","SG9999014906.USD","IE000F7OJYX1.SGD","01093","LU1880407132.USD","BK4007","LU2750360997.AUD","LU0575583348.USD","LU0140636845.USD","KURE","BK1515","LU2236285917.USD","BNTX","LU1813983027.USD","LU0321505868.SGD","LU0158827948.USD","LU0238689110.USD","01801","IE0008368742.USD","LU2468319806.SGD","IE00BZ08YR35.GBP","BK4516","TRUH","LU2242652126.USD","LU0058720904.USD","LU1202635105.USD","AGNG","LU0942090050.USD","SG9999015986.USD","REGN","IE00BLSP4239.USD","BK1588","LU0158827781.USD","LU1003076772.USD","LU0784385840.USD","LU0211326839.USD","LU0784385170.HKD","LU0553294199.USD","LU0545562505.USD","LU2097828805.USD","LU2488822045.USD","LU1894683264.USD","LU0496365809.HKD","LU2125154778.USD","LU2237443382.USD","LU2462591350.SGD","GDOC","LU2097828714.EUR","02096","LU3187612489.SGD","LU0963555726.SGD","LU2360106947.USD","LU0784383803.USD","RHHBY","MEDI","IE00BFXG1179.USD","LU1585245621.USD","LU0985320562.USD","LU2471134879.HKD","IE000M9KFDE8.USD","SG9999003800.SGD","SG9999017495.SGD","LU0237698245.USD","LU0070302665.USD","OZEM","688506","600276","LU2580892789.USD","LU0417516571.SGD","IE00B2B36J28.USD","LU0823434583.USD","LU0757432116.USD","IE0034235071.USD","LU0964806797.USD","LU2089283258.USD","LU1820825898.SGD","LU2347655073.USD","LU0211327993.USD","LU0203345920.USD","IE00BN8TJ469.HKD","LU0708994859.HKD","LU0161305163.EUR","LU2471134952.CNY","LU2750360641.GBP","IE00B5MMRT66.SGD","LU0820561818.USD","SG9999018865.SGD","LU0920783379.SGD","LU0267386448.USD","LU1066053197.SGD","VHT","LU1032466523.USD","LU0079474960.USD","IE00BGHQF631.EUR","IYH","LU2746668461.USD","IE00BKPKM643.USD","LU2087625088.SGD","LU2756315318.SGD","LU2476274308.USD","LU0149534421.HKD","BK4139","LU2087621335.USD","IBBQ","LU1152091168.USD","LU2097828631.EUR","LU2462157665.USD","LU1934455863.HKD","LU2063271972.USD","LU1146622755.USD","LU1064131003.USD","BK4581","LU1015430645.USD","LU1323610961.USD","LU2476274720.SGD","LU0011850046.USD","LU1145028129.USD","LU2433249047.HKD","LU0097036916.USD","LU0171293334.USD","LU1037948541.HKD","LU0857590862.USD","LU2552382058.USD","LU2023250504.SGD","LU1226287875.USD","LU0969580561.USD","IE00BZ08YT58.USD","MEDX","LU1153585028.USD","LU0689472784.USD","PJP","IE00BZ08YS42.EUR","LU0348825331.USD","LU0972486137.USD","NVS","LU0949170772.SGD","RXL","BK0060","LU1051770623.HKD","LU0162691827.USD","LU1064131342.USD","LU0225771236.USD","IE00BJJMRY28.SGD","LU1232071149.USD","LU1571399168.USD","LU1153584641.USD","LU0827474353.SGD","LU1670711040.USD","BK0239","LU0320765992.SGD","LU2756315664.SGD","LU0880133367.SGD","03692","LU1061106388.HKD","LU1794554557.SGD","ELIL","LU1868836914.USD","LU0920840948.USD","LU1804176565.USD","LU0501845795.SGD","BK5011","LU1720051108.HKD","LU0882574139.USD","LU2289578879.USD","LU2361044949.HKD","SGXZ99366536.SGD","LU2399975544.HKD","LU0987226296.USD","LU0980610538.SGD","PAWZ","09926","LU2106854487.HKD","LU0965508806.USD","IE00BJJMRX11.SGD","LU0069063385.USD","LU0124676726.USD","LU0320765059.SGD","LU1098665638.USD","IE0004445015.USD","LU1196032939.SGD","BK4548","CANC","LU1078025761.USD","LU1868836757.USD","LU1969619763.USD","LU1691799644.USD","SGXZ81514606.USD","LU0861579265.USD","LU0289961442.SGD","IE0000B7K699.USD","LU0466842654.USD","LU0310800965.SGD","LU2089984988.USD","LU1712237335.SGD","LU2133065610.SGD","LU0114720955.EUR","LU1037948897.HKD","LU2213496289.HKD","LU0320765646.SGD","LU2491049909.HKD","SG9999002232.USD","SG9999011175.SGD","SGXZ51526630.SGD","LU0405327148.USD","SG9999002224.SGD","LU0061475181.USD","LU1035773651.USD","LU0067412154.USD","BK0188","LU2237443465.HKD","IE00BWDBJ516.SGD","LU1057294990.SGD","LU1236620750.USD","LU1894683348.USD","LU1226287792.SGD","LU1255011170.USD","LU0133085943.USD","LU1670627923.USD","LU2108987350.USD","LU0557290698.USD","LU1580142542.USD","SG9999015945.SGD","IE00B3PB1722.GBP","LU2279689827.SGD","SGXZ57979304.SGD","LU0348784397.USD","LU2125909247.SGD","SG9999014914.USD","NVOH","BK4568","LU0211326755.USD","LU1829250122.USD","LU0390134368.USD","LU0683600562.USD","SG9999015952.SGD","LU0502904849.HKD","LU1023059063.AUD","IHE","LU2539964713.USD","LU2552382215.SGD","LU1481600234.SGD","IE0001KFT4U8.USD","LU0171276677.USD","LU2242646821.SGD","688331","LU1066051498.USD","LU0545039389.USD","SG9999015341.SGD","LU0316494557.USD","IE00BN29S564.USD","LU2211815571.USD","LU1064130708.USD","LU0348827113.USD","LU0726765562.USD","LU0128525689.USD","LU0348766576.USD","SG9999014567.USD","LU2125909593.SGD","LU0094547139.USD","LU1400636574.HKD","IE00B3M56506.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU0792757196.USD","IBB","LU1670628061.USD","LU2129689431.USD","SG9999001440.SGD","BK4585","LU0738911758.USD","LU0957799991.USD","LU0971552673.USD","LU2114397693.USD","LU1366192091.USD","SG9999014559.SGD","SG9999015358.SGD","SGXZ31699556.SGD","LLYX","LU1170363599.USD","SMMT","LU1035777561.USD","LU1328277881.USD","LU1267930227.SGD","LU1119994496.HKD","IE00BJLML261.HKD","SG9999001176.USD","LU2602419157.SGD","LU0912757837.SGD","LU1291159041.SGD","LU2111349929.HKD","LU1162221912.USD","LU0964807845.USD","LU0417517546.SGD","LU0648001328.SGD","LU0689626769.HKD","LU0310800379.SGD","LU0345770308.USD","LU0887340254.USD","LU1951186391.HKD","LU0130517989.USD","IE000BZT7R73.USD","LU1093756325.SGD","BK4533","LU1863844665.USD","LU0072461881.USD","BK0028","IE00BKPKM429.USD","LU0211331839.USD","LU0047473722.SGD","SG9999014542.SGD","BK1191","LU0106261372.USD","BMED","LU0130102774.USD","LU1430594728.SGD","LU1655091616.SGD","LU1645745479.HKD","LU0455707207.USD","LU0949170426.SGD","LU1046248800.SGD","SG9999001176.SGD","IE000MB6IJN5.SGD","LU0960981461.USD","LU2357627491.SGD","IE00BFTCPJ56.SGD","LU1863844749.USD","LU0234570918.USD","MHIP","BK1589","LU0471298694.HKD","GLAM","LU0395794307.EUR","LU2361045086.USD","LU1960683339.HKD","00013","IE0005OL40V9.USD","LU1839511570.USD","JDOC","LU0265550359.USD","LU2461242641.AUD","LU2324357040.USD","LU2112291526.USD","LU0057025933.USD","IE000SO60NU8.SGD","LU0077335932.USD","LU1074936037.SGD","LU0310799852.SGD","LU1629891620.HKD","LU0405327494.USD","LU0985481810.HKD","LU0795875169.SGD","LU1883839398.USD","LU0320765489.SGD","LU1997245177.USD","LU0321505439.SGD","LU1880407215.USD","IE00BDGV0183.EUR","LU0882574055.USD","LU0098860793.USD","LU0868494708.USD","LU2237443622.USD","IE00B19Z3581.USD","LU0820562030.AUD","LU0345777659.USD","LU1104425308.USD","LU1988902786.USD","LU2778985437.USD","TMED","LU2168564222.USD","LU2362540622.SGD","LU0174119429.USD","03933","LU0354030438.USD","LU0526926950.USD","LU0203347892.USD","LU1267930813.SGD","SG9999015978.USD","LU1989771016.USD","IE00BVYPNW00.USD","SG9999014575.USD","LU0820561909.HKD","LU1267930730.SGD","01530","LU2347655156.SGD","IE00BJJMRZ35.SGD","LU0170899867.USD","LU1228905540.USD","LU0198837287.USD","LU1718418525.SGD","LU2168564149.EUR","03165","LU1355424745.HKD","LU0210536198.USD","LU1226287529.USD","IE00BWXC8680.SGD","LU2089284900.SGD","LU1720050803.USD","LU0859254822.USD","LU2357305700.SGD","LU0306806265.USD","LU1244550221.USD","FTXH","IE00BLSP4452.SGD","IE0009355771.USD","BMY","LU0256863902.USD","LU0315179316.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU1236620834.HKD","LU2023251221.USD","LU2271345857.HKD","GSK.UK","CURE","LU0353189680.USD","LU1309081286.SGD","LU0823434740.USD","ELIS","LU0029864427.USD","LU1066051225.USD","LU0477156953.USD","NVO","SG9999013999.USD","IE00BFSS7M15.SGD","IE00B3T34201.USD","IE0034235188.USD","LU1868836591.USD","LU2168564065.EUR","LU1979441026.SGD","LU1917777945.USD","BK4532","LU0225284248.USD","LU2023250843.SGD","IE00B4R5TH58.HKD","LU1201861249.SGD","IE00B543WZ88.USD","ILDR","LU0256863811.USD","LU2495084118.USD","SG9999018857.SGD","LU1548497426.USD","LU1400636491.USD","LU1226288253.USD","LU1301847155.USD","HCM","LU2896262040.SGD","FHLC","LU0463099449.HKD","NVOX","LU0471298777.SGD","LU2242644610.SGD","IE0002270589.USD","LU2746668974.SGD","LU2023250330.USD","LU2293690082.USD","LLII","BK1587","IE00B031HY20.USD","IXJ","LU0889565916.HKD","ABBV","PPH","LU0203201768.USD","LU1732799900.SGD","BK1574","LU1152091754.HKD","LU1046234339.USD","LU2456880835.USD","LU1084165304.USD","LU1868837136.USD","LU1551013342.USD","LU1941712348.USD","LU0128525929.USD","IE00BZ1G4Q59.USD","BK4551","LU0265550946.USD","LU0289739699.SGD","LU0787776722.HKD","LU1069347547.HKD","IE0004445239.USD","LU1188198961.HKD","LU2237443978.SGD","BK1521","HRTS","LU1732800096.USD","MRK","BK4592","LU0047473722.EUR","LU1116320901.HKD","LU1997244956.HKD","LU2129689514.USD","IE00BPRC5H50.USD","LU1069344957.HKD","LU0348767384.USD","LU0943347566.SGD","LU1328615791.USD","LU0306807586.USD","LU1929549753.HKD","BK4566","BK4550","LU2328871848.SGD","BK1583","LU0976567544.SGD","LU2355687059.USD","LU2237438978.USD","LU0511384066.AUD","LU1934455194.USD","BK4599","BK4534","LU1302929846.USD","BK4588","LU1127390331.HKD","TBXU","LU1487256676.USD","LU1670710661.SGD","LU1008478684.HKD","LU0348735423.USD","LU1064927863.SGD","LU0345770993.USD","LU0211328371.USD","LU0672654240.SGD","IE00B7KXQ091.USD","LU0965509101.SGD","BK4578","LU0786609619.USD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU1280957306.USD","BK4559","LU1093756168.USD","LU1267930573.SGD","BBH","IE000WAW04H5.SGD","LU1228905037.USD","01276","LU0823399737.USD","LU0234572021.USD","LU0868494617.USD","LU0561508036.HKD","LU1261432733.SGD","LU1699723380.USD","LU1831875114.USD","LU0326950275.SGD","LU0965509010.AUD","LU0417516902.SGD","LU1003077747.HKD","LU1781817850.SGD","LU1961090484.USD","LU2237443549.SGD","LU2471134523.USD","LU0784384876.USD","LU1989772923.USD","LU0640478417.SGD","IE00BSNM7G36.USD","LU0052756011.USD","LU2148510915.USD","IE0002141913.USD","SG9999014880.SGD","LU2471134796.USD","LU2417539215.USD","LU1670710588.SGD","LU0208291251.USD","LU0348783233.USD","IE00B1XK9C88.USD","LU1670711123.USD","LU2491050071.SGD","LLY","LU1923622614.USD","XLV","LU0314109678.HKD","LU1244550577.SGD","LU0634319403.HKD","GB00BDT5M118.USD","LU2237443895.HKD","LU1997245094.SGD","LU2293690249.USD","LU1941712264.USD","LU1267930490.SGD","LU2265009873.SGD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","LU0971552830.HKD","LU1868837300.USD","IE00BBT3K403.USD","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672792039","title":"AstraZeneca & Daiichi Sankyo Announce Clinical Collaboration with Summit Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2672792039","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672792039?lang=en_us&edition=fundamental","pubTime":"2026-10-02 14:41","pubTimestamp":1790923306,"startTime":"0","endTime":"0","summary":"BRIEF-AstraZeneca & Daiichi Sankyo announce clinical collaboration with Summit TherapeuticsOct 2 (Reuters)-AstraZeneca PLCAZN.L:ASTRAZENECA PLC  - AZ & DS COLLABORATION WITH SUMMIT FOR DATROWAYASTRAZE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUC2B9MS4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565080.SGD","LU1267930813.SGD","LU0557290698.USD","LU0122379950.USD","BK5011","LU0823399737.USD","LU0553294199.USD","LU0345777659.USD","LU0997586515.USD","LU2237443622.USD","03165","LU2091194634.USD","SMMT","LU0784385170.HKD","BK4139","LU1291159041.SGD","LU2108987350.USD","LU2125909593.SGD","LU0545039389.USD","LU1084165304.USD","LU0058720904.USD","LU2357627491.SGD","LU0128525689.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU1003076772.USD","LU1267930573.SGD","LU0526926950.USD","LU0661504455.SGD","LU1015430645.USD","LU0784384876.USD","LU0784383803.USD","LU0889566641.SGD","IE00B4R5TH58.HKD","LU1019632923.USD","LU2237443465.HKD","LU0289739699.SGD","LU0823416689.USD","LU1814569148.SGD","LU2279689827.SGD","LU0960981461.USD","LU2114397693.USD","LU1267930227.SGD","LU1923622614.USD","AZN.UK","LU0266013472.USD","LU0859254822.USD","LU0708994859.HKD","LU0792757196.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672921057","title":"Summit Therapeutics Partners with AstraZeneca, Daiichi Sankyo to Test Ivonescimab with Datroway in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672921057","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672921057?lang=en_us&edition=fundamental","pubTime":"2026-10-02 14:30","pubTimestamp":1790922644,"startTime":"0","endTime":"0","summary":"Summit Therapeutics partners with AstraZeneca, Daiichi Sankyo to test ivonescimab with Datroway in solid tumorsSummit Therapeutics entered a clinical trial collaboration with AstraZeneca and Daiichi S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL68PwCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345777659.USD","LU0077335932.USD","LU0964806797.USD","LU1496350502.SGD","LU0960981461.USD","LU0390134368.USD","LU1814569148.SGD","LU2089283258.USD","LU2091194634.USD","LU0211326839.USD","LU2539964713.USD","LU0957799991.USD","LU1301847155.USD","LU2108987350.USD","SMMT","LU2468319806.SGD","LU0708994859.HKD","LU2355687059.USD","IE00BKPKM643.USD","LU2293690082.USD","LU0266013472.USD","IE0009355771.USD","LU1267930573.SGD","LU1989772840.SGD","LU0640478417.SGD","LU2089984988.USD","LU1863844665.USD","IE0002141913.USD","LU0122379950.USD","LU2133065610.SGD","LU2237443549.SGD","LU2433249047.HKD","LU0997586515.USD","LU0345777147.USD","LU0887340254.USD","LU0171276677.USD","03165","LU1880407132.USD","LU1880407215.USD","LU1119994496.HKD","LU1989771016.USD","LU0289739699.SGD","LU0128525929.USD","LU1104425308.USD","LU0052756011.USD","LU1153584641.USD","LU2125909247.SGD","LU1003077747.HKD","LU0738911758.USD","AZN.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672792452","title":"AstraZeneca - Co, Daiichi Sankyo, Summit to Contribute to Trial Costs and Retain Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2672792452","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672792452?lang=en_us&edition=fundamental","pubTime":"2026-10-02 14:30","pubTimestamp":1790922601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUC2B9MS4:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0557290698.USD","LU0345777659.USD","LU2114397693.USD","LU2433249047.HKD","SG9999013999.USD","LU1323610961.USD","IE0002141913.USD","IE00BKPKM643.USD","LU2237443382.USD","LU0949170772.SGD","LU0052756011.USD","IE00B2B36J28.USD","LU1261432733.SGD","LU0499090636.EUR","LU0545039389.USD","LU0432979614.USD","LU1829250122.USD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0345777147.USD","LU0969580561.USD","LU0827474353.SGD","LU1863844665.USD","LU0920783379.SGD","LU1019632923.USD","03165","LU1046234339.USD","LU1923622614.USD","LU1267930813.SGD","AZN.UK","LU0047473722.SGD","LU1057294990.SGD","SMMT","LU1291159041.SGD","LU0211326755.USD","LU1355424745.HKD","LU0128525929.USD","LU2357627491.SGD","SG9999001176.USD","LU2023251221.USD","LU0029864427.USD","LU0887340254.USD","LU1989772840.SGD","LU0661504455.SGD","LU2089284900.SGD","LU2089984988.USD","LU0390134368.USD","LU1196032939.SGD","LU0708994859.HKD","LU0920840948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672921147","title":"Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with Trop2-Directed ADC Datroway","url":"https://stock-news.laohu8.com/highlight/detail?id=2672921147","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672921147?lang=en_us&edition=fundamental","pubTime":"2026-10-02 14:30","pubTimestamp":1790922600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA89NCJB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","SMMT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757170","title":"Summit Therapeutics is Maintained at Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757170?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:03","pubTimestamp":1790859780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SMMT/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","LU2488822045.USD","SMMT","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672975637","title":"Summit Therapeutics Inc. : Barclays Raises Target Price to $20 from $18","url":"https://stock-news.laohu8.com/highlight/detail?id=2672975637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672975637?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:03","pubTimestamp":1790849005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SMMT","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755431","title":"Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755431?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:20","pubTimestamp":1790846446,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-absci-absi-summit-therapeutics-smmt-and-sutro-biopharma-stro-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","ABSI","BK4539","BK4585","XBI","BK4137","LU2488822045.USD","BK4581","ARKG","SMMT","STRO","XLV","HCSG","BK4121","LABU","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142655681","title":"Movement Alert｜Summit Therapeutics PLC Rises 5.03% in Regular Trading, AstraZeneca $2 Billion Investment Continues to Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1142655681","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142655681?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:55","pubTimestamp":1790780109,"startTime":"0","endTime":"0","summary":"On September 30, Summit Therapeutics PLC rose 5.03% in regular trading, trading at approximately $17.21 per share, with turnover of $57.72 million. The stock continued its upward momentum following a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Summit Surges as AstraZeneca's $2B Investment Fuels Rally","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671051201","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2671051201","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671051201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:17","pubTimestamp":1790770671,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsSept 30 (Reuters)-Novo NordiskNOVOb.COsaid on Tuesday it will pay up to$2.6 billionto Jiangsu Hengrui Pharmaceuticals600276.SSfor the rights t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M0T3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","WDNA","MEDI","CANC","PAWZ","01530","JDOC","BNTX","GDOC","03692","IXJ","MHIP","MEDX","RXL","ILDR","ABBV","BMED","LLYZ","688331","TRUH","IYH","AGNG","XLV","PPH","PJP","ELIL","IHE","THNR","FTXH","CURE","OZEM","TMED","GSK.UK","HRTS","FHLC","PFE","VHT","KURE","00013","01801","600276","LLY","SMMT","ELIS","GLAM","RSHO","LLII","CGNX","09926","LLYX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.smmttx.com","stockEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.1259},{"period":"6month","weight":-0.1271},{"period":"1year","weight":-0.2644},{"period":"ytd","weight":-0.0183}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.093233},{"month":2,"riseRate":0.454545,"avgChangeRate":0.0357},{"month":3,"riseRate":0.454545,"avgChangeRate":0.039344},{"month":4,"riseRate":0.5,"avgChangeRate":0.042597},{"month":5,"riseRate":0.5,"avgChangeRate":0.075963},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.093606},{"month":7,"riseRate":0.583333,"avgChangeRate":0.072153},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002579},{"month":9,"riseRate":0.416667,"avgChangeRate":0.08925},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.042597},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.015842},{"month":12,"riseRate":0.454545,"avgChangeRate":0.356783}],"exchange":"NASDAQ","name":"Summit Therapeutics PLC","nameEN":"Summit Therapeutics PLC","securityTypeName":"DR","adrRate":"1:5"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Summit Therapeutics PLC(SMMT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Summit Therapeutics PLC(SMMT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Summit Therapeutics PLC,SMMT,Summit Therapeutics PLC股票,Summit Therapeutics PLC股票老虎,Summit Therapeutics PLC股票老虎国际,Summit Therapeutics PLC行情,Summit Therapeutics PLC股票行情,Summit Therapeutics PLC股价,Summit Therapeutics PLC股市,Summit Therapeutics PLC股票价格,Summit Therapeutics PLC股票交易,Summit Therapeutics PLC股票购买,Summit Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Summit Therapeutics PLC(SMMT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Summit Therapeutics PLC(SMMT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}